• 17 JUL 14
    • 0

    Review on clinical studies with cannabis and cannabinoids 2005-2009

    Review on clinical studies with cannabis and cannabinoids 2005-2009 

    • 25 NOV 13
    • 0

    Provenge, first autologous cellular immunotherapy to prolong survival in prostate cancer

    PROVENGE(R) (sipuleucel-T) demonstrated a statistically significant improvement in overall survival compared to control in men with asymptomatic or minimally symptomatic metastatic castration resistant prostate cancer New England Journal of Medicine Publishes Data from Pivotal Phase 3 PROVENGE IMPACT Study First Autologous Cellular Immunotherapy to Prolong Survival in Cancer SEATTLE, July 28, 2010 /PRNewswire via COMTEX/

    • 25 NOV 13
    • 0

    Progress occurs by leaps and bounds not by incremental change

    Progress occurs by leaps and bounds not by incremental change. Author Robert W. Gorter, MD, PhD. Progress occurs by leaps and bounds not by incremental change Author: Robert W. Gorter, MD, PhD. The incremental improvement of standard therapies through improved surgical techniques, radiation, chemotherapy or medications that can be patented or slight changes in treatment

    • 24 NOV 13
    • 0

    Privacy policy

    Privacy policy How Personal Information Is Used  We use the personal information that you provide for such purposes as: -Completion and support of the activity for which the information was provided, such as allowing access to or delivery of our products or services, processing or fulfilling an order, or responding to your requests or inquiries;